Insider Selling: Alignment Healthcare (NASDAQ:ALHC) President Sells 30,000 Shares of Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) President Dawn Christine Maroney sold 30,000 shares of the business’s stock in a transaction on Tuesday, February 17th. The shares were sold at an average price of $20.63, for a total transaction of $618,900.00. Following the completion of the sale, the president directly owned 997,015 shares of the company’s stock, valued at approximately $20,568,419.45. This trade represents a 2.92% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Dawn Christine Maroney also recently made the following trade(s):

• On Thursday, January 15th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $22.48, for a total value of $674,400.00.
• On Tuesday, January 6th, Dawn Christine Maroney sold 228,152 shares of Alignment Healthcare stock. The stock was sold at an average price of $21.33, for a total value of $4,866,482.16.
• On Friday, January 2nd, Dawn Christine Maroney sold 100,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $20.03, for a total value of $2,003,000.00.
• On Monday, December 29th, Dawn Christine Maroney sold 282,070 shares of Alignment Healthcare stock. The stock was sold at an average price of $18.74, for a total value of $5,285,991.80.
• On Monday, December 15th, Dawn Christine Maroney sold 113,319 shares of Alignment Healthcare stock. The stock was sold at an average price of $20.01, for a total value of $2,267,513.19.
• On Friday, December 12th, Dawn Christine Maroney sold 16,681 shares of Alignment Healthcare stock. The shares were sold at an average price of $20.02, for a total value of $333,953.62.

Alignment Healthcare Stock Performance

Shares of ALHC stock traded up $0.40 during trading hours on Tuesday, hitting $20.59. The stock had a trading volume of 2,552,970 shares, compared to its average volume of 2,680,118. The company has a debt-to-equity ratio of 1.99, a current ratio of 1.61 and a quick ratio of 1.61. The firm has a market capitalization of $4.12 billion, a PE ratio of -171.58, a PEG ratio of 5.14 and a beta of 1.16. The stock’s 50 day moving average is $20.95 and its 200 day moving average is $18.23. Alignment Healthcare, Inc. has a twelve month low of $11.63 and a twelve month high of $23.87.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the stock. Parallel Advisors LLC boosted its stake in shares of Alignment Healthcare by 87.7% during the 4th quarter. Parallel Advisors LLC now owns 1,654 shares of the company’s stock worth $33,000 after acquiring an additional 773 shares in the last quarter. Larson Financial Group LLC acquired a new stake in Alignment Healthcare in the third quarter valued at $33,000. First Horizon Corp purchased a new position in shares of Alignment Healthcare in the fourth quarter valued at $39,000. SBI Securities Co. Ltd. raised its stake in shares of Alignment Healthcare by 4,868.9% during the 2nd quarter. SBI Securities Co. Ltd. now owns 3,031 shares of the company’s stock worth $42,000 after buying an additional 2,970 shares during the last quarter. Finally, GAMMA Investing LLC boosted its position in shares of Alignment Healthcare by 83.8% in the 4th quarter. GAMMA Investing LLC now owns 2,165 shares of the company’s stock worth $43,000 after buying an additional 987 shares in the last quarter. 86.19% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

ALHC has been the subject of a number of research reports. Piper Sandler upped their target price on shares of Alignment Healthcare from $20.00 to $30.00 and gave the company an “overweight” rating in a report on Tuesday, January 6th. Wall Street Zen raised Alignment Healthcare from a “hold” rating to a “buy” rating in a research note on Saturday, February 7th. Robert W. Baird set a $28.00 price objective on Alignment Healthcare in a research report on Friday, January 30th. KeyCorp restated an “overweight” rating and set a $28.00 price target on shares of Alignment Healthcare in a research note on Thursday, January 22nd. Finally, JPMorgan Chase & Co. lifted their price objective on shares of Alignment Healthcare from $23.00 to $26.00 and gave the company an “overweight” rating in a research report on Thursday, February 5th. One equities research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, three have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, Alignment Healthcare currently has a consensus rating of “Moderate Buy” and a consensus price target of $23.32.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.